Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “Biomedical Research”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 667 records · Page 37

Toxic Substances Registry System. Index of Material Safety Data Sheets

The October 1994 revision of the KSC Toxic Substances Registry System (TSRS) Material Safety Data Sheets (MSD's) is presented. The listed MSD's which were submitted to the TSRS are maintained by the Base Operations Contractors of the Biomedical Operations and Research Office of KSC. The purpose of the index is to provide a means of accessing information on the hazards associated with the toxic and otherwise hazardous chemicals stored and used at KSC. Indices are provided for manufacturers, trademarks, and stock numbers.

Source record↗

Toxic substances registry system. Index of material safety data sheets

The January 1995 revision of the index of material safety data sheets is presented. The index of toxic substances is divided by maufacturer, tradename, stock number, and distributor. This index provides a means of accessing information including hazards, uses, and chemical composition of materials stored and used at KSC's Biomedical Operations and Research Office.

Source record↗

Benchmarks: Reports of the NASA Science Institutes Team

This report results from a benchmarking study undertaken by NASA as part of its planning for the possible creation of new science Institutes. Candidate Institutes under consideration cover a range of scientific and technological activities ranging from biomedical to astrophysical research and from the global hydrological cycle to microgravity material science. Should NASA create these Institutes, the intent will be to preserve and strengthen key science and technology activities now being performed by Government employees at NASA Field Centers. Because the success of these projected non-Government-operated Institutes is vital for the continued development of space science and applications, NASA has sought to identify the best practices of successful existing scientific and technological research institutions as they carry out those processes that will be most important for the new science Institutes. While many individuals and organizations may be interested in our findings, the primary use of this report will be to formulate plas for establishing the new science Institutes. As a result, the report is organized to that the "best practices" of the finest institutes are associated with characteristics of all institutes. These characteristics or "attributes" serve as the headings for the main body of this report.

Diaz, A. V.↗

From Project Mercury to the Breadboard Project

NASA's Project Mercury began as a response to the cold war with the Soviet Union and had a number of goals: to place a manned spacecraft in orbital flight around the earth; to investigate man's performance capabilities and his ability to function in the environment of space and to recover the man and the spacecraft safely. One aspect of preflight testing included the use of an altitude chamber to test each capsule and allow the astronauts to engage in simulated missions within a vacuum environment. Flash forward to 1985. The Biomedical Operations and Research Office at Kennedy Space Center proposed to use the chamber for an unusual mission under what was known as the Controlled Ecological Life Support Systems (CELSS)Breadboard Project. During 1985 into 1987, the chamber was converted to an environmentally-controlled, hydroponic plant growth chamber termed the "Biomass Production Chamber" and operated through late 2001.

Dreschel, Thomas W.↗

National User Resource for Biological Accelerator Mass Spectrometry

The National User Resource for Biological Accelerator Mass Spectrometry (User Resource) will provide isotopic analysis (primarily radiocarbon or 14C) by accelerator mass spectrometry (AMS) for NIH- funded researchers across the United States and will be the only User Resource of its type in the United States. The User Resource will provide measurement capability and expertise to a research community that requires highly sensitive, quantitative isotope analyses. Since commissioning a new accelerator mass spectrometer in June 2014, we have measured over 4000 samples a year for collaborators and service users. The User Resource will enable us to continue to meet these research needs, as well as provide for new users whose research programs would benefit from AMS as a measurement tool. The User Resource’s forte will be ultra-high sensitivity quantitation of radiocarbon and selected other radioisotopes for research studies where isotopes are required. Radioisotope labeling studies have been and will continue to be an important tool for addressing many complex biomedical science problems. AMS is a specialized and unique type of mass spectrometry that provides absolute quantitation of radiocarbon and other relevant radioisotopes with extreme sensitivity, having limits of detection in real samples on the order of a few attomol/mg of sample at measurement precisions of ~3%. It is the only instrumental method capable of quantifying radioisotope-labeled agents routinely in real-world samples with such precision and sensitivity. The sensitivity of AMS allows for the quantification of radiolabeled metabolites in extremely complex matrices of cells and organisms at very low concentrations and in small samples. AMS allows studies to be conducted without perturbing metabolism leading to more relevant quantification of metabolic rates and pathways. In addition, it enables quantification of pharmacokinetic and metabolic properties of toxicants at environmentally relevant concentrations in model systems as well as the ability to quantify pharmacokinetics and other molecular endpoints directly in humans. Such quantitative assessments can 1) improve risk assessment for toxicants, 2) address safety and efficacy considerations for therapeutic entities, 3) deepen understanding of xenobiotic and intermediary metabolism, 4) help understand the interactions between critical molecular pathways, and 5) improve efforts to model and predict various metabolic and biological states. These capabilities have been applied in a number of areas including research in carcinogenesis, toxicology, nutrition, pharmacology/drug development and basic biological science. As a NIGMS National Resource the National User Resource for Biological Accelerator Mass Spectrometry will help NIH funded scientists achieve a deeper understanding of the etiology of human health concerns by (1) enabling the quantification of pharmacokinetics and other molecular endpoints directly in humans; (2) offering the ability to conduct quantitative studies using biologics such as proteins or lipids, and thereby reducing the amount of radioisotope usage in biomedical labs; and (3) enabling more relevant studies of metabolic pathways in health and disease through the use of much lower, more biologically-relevant, concentrations of metabolic substrates in cells and intact organisms. Such studies support NIGMS’s basic biomedical research areas that contribute to the understanding of fundamental cellular and physiological principles and enable research supported by the Biophysics, Biomedical Technology, and Computational Biosciences (BBCB); Genetics and Molecular, Cellular, and Developmental Biology (GMCDB); Pharmacology, Physiology, Biological Chemistry (PPBC) and Training, Workforce Development, and Diversity (TWD) Divisions.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

Image Informatics for Clinical and Preclinical Biomedical Analysis

Biomedical informatics refers to the study of the application of computationaland statistical algorithms, data structures, and methods to improve communication, understanding and management of biomedical information. Our objective through this chapter is to describe and demonstrate our research in the use of biomedical image databases - in both preclinical and clinical settings - to classify, predict, research, diagnose, and otherwise learn from the informational content encapsulated in historical image repositories. This will be accomplished by detailing our approach of describing image content in a Bayesian probabilistic framework to achieve learning from retrieved populations of similar images. We will use specific examples from two biomedical applications to describe anatomic segmentation, statistical featuregeneration and indexing, efficient retrieval architectures, and predictive results.

60 APPLIED LIFE SCIENCES↗

Capturing phenotypes for precision medicine

Deep phenotyping followed by integrated computational analysis of genotype and phenotype is becoming ever more important for many areas of genomic diagnostics and translational research. The overwhelming majority of clinical descriptions in the medical literature are available only as natural language text, meaning that searching, analysis, and integration of medically relevant information in databases such as PubMed is challenging. The new journal Cold Spring Harbor Molecular Case Studies will require authors to select Human Phenotype Ontology terms for research papers that will be displayed alongside the manuscript, thereby providing a foundation for ontology-based indexing and searching of articles that contain descriptions of phenotypic abnormalities —an important step toward improving the ability of researchers and clinicians to get biomedical information that is critical for clinical care or translational research.

59 BASIC BIOLOGICAL SCIENCES↗

Translational Cellular Research on the International Space Station

The emerging field of Translational Research aims to coalesce interdisciplinary findings from basic science for biomedical applications. To complement spaceflight research using human subjects, translational studies can be designed to address aspects of space-related human health risks and help develop countermeasures to prevent or mitigate them, with therapeutical benefits for analogous conditions experienced on Earth. Translational research with cells and model organisms is being conducted onboard the International Space Station (ISS) in connection with various human systems impacted by spaceflight, such as the cardiovascular, musculoskeletal, and immune systems. Examples of recent cell-based translational investigations on the ISS include the following. The JAXA investigation Cell Mechanosensing seeks to identify gravity sensors in skeletal muscle cells to develop muscle atrophy countermeasures by analyzing tension fluctuations in the plasma membrane, which changes the expression of key proteins and genes. Earth applications of this study include therapeutic approaches for some forms of muscular dystrophy, which appear to parallel aspects of muscle wasting in space. Spheroids is an ESA investigation examining the system of endothelial cells lining the inner surface of all blood vessels in terms of vessel formation, cellular proliferation, and programmed cell death, because injury to the endothelium has been implicated as underpinning various cardiovascular and musculoskeletal problems arising during spaceflight. Since endothelial cells are involved in the functional integrity of the vascular wall, this research has applications to Earth diseases such as atherosclerosis, diabetes, and hypertension. The goal of the T-Cell Activation in Aging NASA investigation is to understand human immune system depression in microgravity by identifying gene expression patterns of candidate molecular regulators, which will provide further insight into factors that may play a critical role in immune function loss during aging. In addition, Omics investigations with cells have synergistic applications ranging from the evaluation of pharmacological countermeasures to drug discovery. Thus, cell-based translational research onboard the ISS is bidirectionally bridging cutting-edge cellular and molecular approaches with space bioastronautics and human health methodologies on Earth.

Love, John↗

Science and technology of biocompatible thin films for implantable biomedical devices.

This presentation focuses on reviewing research to develop two critical biocompatible film technologies to enable implantable biomedical devices, namely: (1) development of bioinert/biocompatible coatings for encapsulation of Si chips implantable in the human body (e.g., retinal prosthesis implantable in the human eye) - the coating involves a novel ultrananocrystalline diamond (UNCD) film or hybrid biocompatible oxide/UNCD layered films; and (2) development of biocompatible films with high-dielectric constant and microfabrication process to produce energy storage super-capacitors embedded in the microchip to achieve full miniaturization for implantation into the human body.

36 MATERIALS SCIENCE↗

Cancer's Big Data Problem

The US Department of Energy (DOE) has partnered with the National Cancer Institute (NCI) to use DOE supercomputers to aid in the fight against cancer by building sophisticated models based on data available at the population, patient, and molecular levels. Here, through a three-year pilot project called the Joint Design of Advanced Computing Solutions for Cancer (JDACSC), four participating national laboratories--Argonne, Lawrence Livermore, Los Alamos, and Oak Ridge--will focus on three problems singled out by the NCI as the biggest bottlenecks to advancing cancer research.

60 APPLIED LIFE SCIENCES↗

Mondo: integrating disease terminology across communities

Precision medicine aims to enhance diagnosis, treatment, and prognosis by integrating multimodal data at the point of care. However, challenges arise due to the vast number of diseases, differing methods of classification, and conflicting terminological coding systems and practices used to represent molecular definitions of disease. This lack of interoperability artificially constrains the potential for diagnosis, clinical decision support, care outcome analysis, as well as data linkage across research domains to support the development or repurposing of therapeutics. There is a clear and pressing need for a unified system for managing disease entities⁠—including identifiers, synonyms, and definitions. To address these issues, we created the Mondo disease ontology—a community-driven, open-source, unified disease classification system that harmonizes diverse terminologies into a consistent, computable framework. Mondo integrates key medical and biomedical terminologies, including Online Mendelian Inheritance in Man (OMIM), Orphanet, Medical Subject Headings (MeSH), National Cancer Institute Thesaurus (NCIt), and more, to provide a comprehensive and accurate representation of disease concepts with fully provenanced and attributed links back to the sources. Mondo can be used as the handle for curation of gene–disease associations utilized in diagnostic applications, research applications such as computational phenotyping, and in clinical coding systems in clinical decision support by pointing the clinician to the numerous knowledge resources linked to the Mondo identifier. Mondo's community-centric approach, stewarded by the Monarch Initiative's expertise in ontologies, ensures that the ontology remains adaptable to the evolving needs of biomedical research and clinical communities, as well as the knowledge providers.

biomedical informatics↗

Opportunities for research on Space Station Freedom

NASA has allocated research accommodations on Freedom (equipment, utilities, etc.) to the program offices that sponsor space-based research and development as follows: Space Science and Applications (OSSA)--52 percent, Commercial Programs (OCP)--28 percent, Aeronautics and Space Technology (OAST)--12 percent, and Space Flight (OSF)--8 percent. Most of OSSA's allocation will be used for microgravity and life science experiments; although OSSA's space physics, astrophysics, earth science and applications, and solar system exploration divisions also will use some of this allocation. Other Federal agencies have expressed an interest in using Space Station Freedom. They include the National Institutes of Health (NIH), U.S. Geological Survey, National Science Foundation, National Oceanic and Atmospheric Administration, and U.S. Departments of Agriculture and Energy. Payload interfaces with space station lab support equipment must be simple, and experiment packages must be highly contained. Freedom's research facilities will feature International Standard Payload Racks (ISPR's), experiment racks that are about twice the size of a Spacelab rack. ESA's Columbus lab will feature 20 racks, the U.S. lab will have 12 racks, and the Japanese lab will have 10. Thus, Freedom will have a total of 42 racks versus 8 for Space lab. NASA is considering outfitting some rack space to accommodate small, self-contained payloads similar to the Get-Away-Special canisters and middeck-locker experiment packages flown on Space Shuttle missions. Crew time allotted to experiments on Freedom at permanently occupied capability will average 25 minutes per rack per day, compared to six hours per rack per day on Spacelab missions. Hence, telescience--the remote operation of space-based experiments by researchers on the ground--will play a very important role in space station research. Plans for supporting life sciences research on Freedom focus on the two basic goals of NASA 's space life sciences program: to ensure the health, safety, and productivity of humans in space and to acquire fundamental knowledge of biological processes. Space-based research has already shown that people and plants respond the same way to the microgravity environment: they lose structure. However, the mechanisms by which they respond are different, and researchers do not yet know much about these mechanisms. Life science research accommodations on Freedom will include facilities for experiments designed to address this and other questions, in fields such as gravitational biology, space physiology, and biomedical monitoring and countermeasures research.

Phillips, Robert W.↗

The value and potential of animal research in enabling astronaut health - Transition from Spacelab to Space Station Freedom

Maintaining astronaut health is a critical aspect of human space exploration. Three decades of space research have demonstrated that microgravity produces significant physiological changes in astronauts. For long-duration missions, the possibility exists that these changes may prevent the achievement of full health and safety and may therefore require countermeasures. Meeting this goal depends on a strong biomedical foundation. Although much research is conducted with humans, some of the most critical work involves a necessary in-depth look into complex problem areas requiring invasive procedures using animals. Much of this research cannot be performed in humans within the bounds of accepted medical practice. A large portion of knowledge and experience in flying animals and applying the data to astronaut health has been obtained through the Spacelab experience and can be applied to a space station situation (expanded to accommodate necessary standardization and flexibility). The objectives of this paper are to (a) discuss the value and potential of animal research in answering critical questions to enable astronaut health for advanced missions, (b) discuss how previous Spacelab operational experience in animal studies can be applied to facilitate transition into a space station era, and (c) review capabilities of biological facilities projected for Space Station Freedom.

Garshnek, V.↗

Final Report for The University of Texas at Arlington Optical Medical Imaging Section of Advanced Imaging Research Center

The goal of this project was to create state-of-the-art optical medical imaging laboratories for the Biomedical Engineering faculty and student researchers of the University of Texas at Arlington (UTA) on the campus of the University of Texas Southwestern Medical Center (UTSW). This has been successfully achieved. These laboratories provide an unprecedented opportunity for the bioengineers (from UTA) to bring about new breakthroughs in medical imaging using optics. Specifically, three major laboratories have been successfully established and state-of-the-art scientific instruments have been placed in the labs. As a result of this grant, numerous journal and conference publications have been generated, patents for new inventions have been filed and received, and many additional grants for the continuation of the research has been received.

42 ENGINEERING↗

Nanoparticles for Biomedical Imaging

Background: Synthetic nanoparticles are emerging as versatile tools in biomedical applications, particularly in the area of biomedical imaging. Nanoparticles 1 to 100 nm in diameter possess dimensions comparable to biological functional units. Diverse surface chemistries, unique magnetic properties, tunable absorption and emission properties, and recent advances in the synthesis and engineering of various nanoparticles suggest their potential as probes for early detection of diseases such as cancer. Surface functionalization has further expanded the potential of nanoparticles as probes for molecular imaging. Objective: To summarize emerging research of nanoparticles for biomedical imaging with increased selectivity and reduced non-specific uptake with increased spatial resolution containing stabilizers conjugated with targeting ligands. Methods: This review summarizes recent technological advances in the synthesis of various nanoparticle probes, and surveys methods to improve the targeting of nanoparticles for their applications in biomedical imaging. Conclusion: Structural design of nanomaterials for biomedical imaging continues to expand and diversify. Synthetic methods have aimed to control the size and surface characteristics of nanoparticles to control distribution, half-life and elimination. Although molecular imaging applications using nanoparticles are advancing into clinical applications, challenges such as storage stability and long-term toxicology should continue to be addressed. Keywords: nanoparticle synthesis, surface modification, targeting, molecular imaging, and biomedical imaging.

59 BASIC BIOLOGICAL SCIENCES↗

25+2 poles, 4.3 T wiggler at BMIT – 7 years operational experience

The research program at the Biomedical Imaging and Therapy (BMIT) Facility at the Canadian Light Source (CLS) required a unique radiation source that would provide a wide beam fan with high critical energy and high dose rates. A superconductive wiggler was the only practical solution that could be installed inside the CLS ring. Design requirements were defined in 2005 [1-2]. The wiggler, optimized for a 3 GeV ring, was to match operating parameters of an equivalent hard X-ray source on a 6 GeV ring. Manufacturing started in 2006 and the wiggler was installed in November of 2007 [3-5]. Several modifications to external hardware and to the power supplies’ controls were implemented to address the air leaks into the He space and to provide the ability to change the field of the wiggler during normal operation without affecting other research groups. The original burst disk and pressure relief valves were replaced with commercial units. Most of the buna O-rings were replaced with metal O-rings, helping to provide air-tightness of external connections. Over the years, the nominal, no-load temperatures went up by 0.3 K at the LHe space and up by 4 K at the 50 K shield space due to deterioration of thermal links and insulation, resulting from thermal cycling and vibrations generated by cryo-coolers. In October of 2014 the wiggler went through major maintenance to improve the thermal links operation, to improve the LHe transfer line connection, to install additional heaters to mitigate potential ice growth, and to provide a separate exhaust path for the rupture disk port.

43 PARTICLE ACCELERATORS↗

STS-107 Mission after the Mission: Recovery of Data from the Debris of Columbia

STS-107 was a 16-day, dedicated research mission that included over 80 experiments, spanning many disciplines including biology, physics, chemistry, and earth sciences, including many student experiments. The mission was considered a resounding success until February 1, 2003, when tragedy struck the Columbia and her crew as she re-entered the atmosphere over Texas. During the mission, approximately one third of the overall data was obtained but much more was stored in the flight hardware systems. This paper documents a new set of STS-107 experiment objectives, a "mission after the mission," in which several experiment teams attempted, and, in many cases succeeded, to recover data from their flight hardware, now debris. A description of the data recovery efforts is included for these five experiment facilities: Combustion Module-2, Critical Viscosity of Xenon-2, Commercial Instrumentation Technology Associates Biomedical Experiments-2, Biological Research in Canisters-14, and Commercial Protein Crystal Growth.

Over, A. P.↗

Research Needs in Electrostatics for Lunar and Mars Space Missions

The new space exploratory vision announced by President Bush on January 14, 2004, initiated new activities at the National Science and Space Administration (NASA) for human space missions to further explore our solar system. NASA is undertaking Lunar exploration to support sustained human and robotic exploration of Mars and beyond. A series of robotic missions to the Moon by 2008 to prepare for human exploration as early as 2015 but no later than 2020 are anticipated. In a similar way, missions to the Moon and Mars are being planned in Europe, Japan and Russia. These space missions will require international participation to solve problems in a number of important technological areas where research is needed, including biomedical risk mitigation as well as life support and habitability on the surface of Mars. Mitigation of dust hazards is one of the most important problems to be resolved for both Lunar and Mars missions. Both Lunar and Martian regolith are unique materials and completely different from the terrestrial soils that we are exposed to on earth. The total absence of water and an atmosphere on the moon and the formation of soil and fine dust by micrometeorite impacts over billions of years resulted in a layer of soil with unique properties. The soil is primarily basaltic in composition with a high glass concentration. The depth of the soil layer varies from a few meters in the mare areas (dark areas on the Lunar near side) to tens of meters in the highland areas (the lighter mountainous areas) and the particle size distribution of this dust layer varies widely with a major mass fraction less than 10 micrometer in diameter. The hard soil from the moon which has been extensively studied by several researchers showed clearly unique properties of Lunar soil. Apollo astronauts became aware of the potentially serious threat to crew health and mission hardware that can be caused by the lunar dust. As reported by McKay and Carrier the mass fraction of the lunar dust with particle diameter smaller than 20p.m probably represents up to 30% of the total mass of regolith. Apollo astronaut Dr. Harrison Schmidt reported that these fine dust particles were clinging to the Extra Vehicular Activity (EVA) suits and to the visors and were limiting the activity on the surface of the moon. The dust particles that were transported with the EVA suits into the lunar module floated throughout the cabin. Crews inhaled the dust particles and noted that they smelled like gun smoke, caused a chocking sensation in the throat and eye irritation. In addition,, some of the mechanical systems were not functioning well because of the dust deposition. It appeared that the dust particles are highly charged electrostatically and Dr. Schmidt noted that future successful Lunar missions will require appropriate dust mitigation technology for protecting astronauts from inhaling toxic particles and mission's life supporting equipment from contamination with the dust particles.

Calle, Carlos I.↗